Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1031240231Active, not recruiting
Open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Nihon University Itabashi Hospital. Primary endpoints: Maximum plasma concentration (Cmax) of ropivacaine and Time to reach maximum plasma concentration (Tmax) of ropivacaine. Started Oct 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1031240231.